WEIGHTED AVERAGE CALCULATIONS FOR POPULATING COST-EFFECTIVENESS MODELS: HOW IGNORING THE MODEL'S CLINICAL PATHWAYS CAN SIGNIFICANTLY BIAS THE INCREMENTAL COST-EFFECTIVENESS RATIO

被引：0

作者：

Van Vlaenderen, I ^{[1
]}

Moeremans, K. ^{[1
]}

Van Bellinghen, L. ^{[1
]}

机构：

[1] CHESS Hlth, Bonheiden, Belgium

来源：

VALUE IN HEALTH | 2018年 / 21卷

关键词：

D O I：

10.1016/j.jval.2018.09.030

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

CP4

引用

页码：S5 / S6

页数：2

共 50 条

[1] AVERAGE COST-EFFECTIVENESS RATIO WITH CENSORED DATA
Bang, Heejung
Zhao, Hongwei
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2012, 22 (02) : 401 - 415
[2] THE BIAS OF IGNORING CARDIOPROTECTIVE EFFECTS IN COST-EFFECTIVENESS ANALYSIS IN DIABETES
Fridhammar, A.
Nilsson, A.
Persson, S.
VALUE IN HEALTH, 2019, 22 : S575 - S575
[3] Problems with interval estimates of the incremental cost-effectiveness ratio
Heitjan, DF
Moskowitz, AJ
Whang, W
MEDICAL DECISION MAKING, 1999, 19 (01) : 9 - 15
[4] Cost-Effectiveness Comparison between Transforaminal and Lateral Lumbar Interbody Fusions Using the Incremental Cost-Effectiveness Ratio
Gandhoke, Gurpreet Surinder
Shin, Han Moe
Chang, Yue Fang
Tempel, Zachary
Gerszten, Peter
Okonkwo, David
Kanter, Adam
JOURNAL OF NEUROSURGERY, 2015, 123 (02) : A532 - A532
[5] Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?
O'Mahony, James F.
PHARMACOECONOMICS, 2020, 38 (08) : 777 - 779
[6] Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?
James F. O’Mahony
PharmacoEconomics, 2020, 38 : 777 - 779
[7] Incremental and average cost-effectiveness ratios: Will physicians make a distinction?
Hershey, JC
Asch, DA
Jepson, C
Baron, J
Ubel, PA
RISK ANALYSIS, 2003, 23 (01) : 81 - 89
[8] Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence
Santoli, Giuseppe
Nurchis, Mario Cesare
Calabro, Giovanna Elisa
Damiani, Gianfranco
VACCINES, 2023, 11 (02)
[9] A clinician's guide to correct cost-effectiveness analysis: Think incremental not average
Hoch, Jeffrey S.
Dewa, Carolyn S.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2008, 53 (04): : 267 - 274
[10] THE IMPACT OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY USAGE ON COST-EFFECTIVENESS: AN ANALYSIS OF THE INCREMENTAL COST-EFFECTIVENESS RATIO (ICER)
Guzman, Nino de Rivera J.
Chavez, G.
VALUE IN HEALTH, 2023, 26 (12) : S185 - S185

← 1 2 3 4 5 →